I had to look up this type of trial, where researchers use a large dataset to put together a hypothetical trial to try and glean causality from correlations. “Semaglutide was associated with 40% to 70% reduced risks of first-time [Alzheimer’s] […]
Much better than a placebo, says this study of over 4,000 participants. It measured changes to “weight-related quality of life (WRQOL) and health-related quality of life (HRQOL)” scores. What I found interesting was that even with the drug, only 40-50% […]
This already-approved drug [Semaglutide] just showed remarkable results. “Nearly 2,000 participants, at 129 centers in 16 countries, injected themselves weekly with semaglutide or a placebo for 68 weeks. Those who got the drug lost close to 15 percent of their […]